INS and type 1 diabetes mellitus: Screening for islet autoantibodies is performed in people with a genetic predisposition for type 1 diabetes to investigate the natural history of the disease and when enrolling patients into interventional trials aimed at delaying the requirement for insulin replacement therapy [1, 3–9].